{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:05:20Z","timestamp":1790255120117,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008100","name":"Southern University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200034"],"award-info":[{"award-number":["82200034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016804","name":"Natural Science Foundation of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20240813115821029"],"award-info":[{"award-number":["JCYJ20240813115821029"]}],"id":[{"id":"10.13039\/100016804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omton.2026.201168","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:04:05Z","timestamp":1772208245000},"page":"201168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiopoietin-like protein 4 deficiency promotes tumor immune infiltration and CD8+ T cell cytotoxic activity to inhibit tumor progression"],"prefix":"10.1016","volume":"34","author":[{"given":"Linjun","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguan Soon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-7837","authenticated-orcid":false,"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201168_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2026.201168_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The Roles of CD8(+) T Cell Subsets in Antitumor Immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.omton.2026.201168_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113068","article-title":"Hypoxia, a key factor in the immune microenvironment","volume":"151","author":"Hu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omton.2026.201168_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12967-024-05134-6","article-title":"CD8(+) T cell-based cancer immunotherapy","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omton.2026.201168_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964442","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201168_bib6","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201168_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100907","article-title":"Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade","volume":"66","author":"Pang","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.omton.2026.201168_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BSR20110102","article-title":"Angiopoietin-like 4: a decade of research","volume":"32","author":"Zhu","year":"2012","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.omton.2026.201168_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1541-7786.MCR-11-0519","article-title":"Emerging roles of angiopoietin-like 4 in human cancer","volume":"10","author":"Tan","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omton.2026.201168_bib10","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41388-018-0592-6","article-title":"Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4","volume":"38","author":"Kolb","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2026.201168_bib11","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/mt.2014.102","article-title":"Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice","volume":"22","author":"Chong","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201168_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.molmed.2019.05.010","article-title":"ANGPTL4 in metabolic and cardiovascular disease","volume":"25","author":"Aryal","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omton.2026.201168_bib13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.celrep.2015.01.011","article-title":"Angiopoietin-like 4 increases pulmonary tissue leakiness and damage during influenza pneumonia","volume":"10","author":"Li","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201168_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2011.01.018","article-title":"Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors","volume":"19","author":"Zhu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2026.201168_bib15","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1182\/blood-2011-01-328716","article-title":"ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters","volume":"118","author":"Huang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201168_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12935-024-03246-z","article-title":"ANGPTL4 regulates ovarian cancer progression by activating the ERK1\/2 pathway","volume":"24","author":"Xu","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.omton.2026.201168_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1186\/s12885-020-07343-w","article-title":"ANGPTL4 overexpression inhibits tumor cell adhesion and migration and predicts favorable prognosis of triple-negative breast cancer","volume":"20","author":"Cai","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2026.201168_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138523","article-title":"RNA-seq shows Angiopoietin-like 4 promotes hepatocellular carcinoma progression by inducing M2 polarization of tumor-associated macrophages","volume":"287","author":"Cui","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.omton.2026.201168_bib19","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2353\/ajpath.2010.100129","article-title":"Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration","volume":"177","author":"Goh","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omton.2026.201168_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2141.2000.02037.x","article-title":"The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage","volume":"109","author":"Kina","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2026.201168_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13045-023-01430-8","article-title":"Novel strategies for cancer immunotherapy: counter-immunoediting therapy","volume":"16","author":"Liu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.omton.2026.201168_bib22","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1158\/1078-0432.CCR-21-1804","article-title":"Cancer Immunoediting in the Era of Immuno-oncology","volume":"28","author":"Gubin","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201168_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201168_bib24","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1158\/2159-8290.CD-22-0603","article-title":"Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes","volume":"12","author":"Newell","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2026.201168_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201168_bib26","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1038\/onc.2017.244","article-title":"Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial-mesenchymal transition by inducing 14-3-3gamma expression","volume":"36","author":"Teo","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2026.201168_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12967-023-04819-8","article-title":"ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2\/STAT3 pathway and interacting with ESM1","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omton.2026.201168_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41587-024-02301-4","article-title":"Patient-derived mini-colons enable long-term modeling of tumor-microenvironment complexity","volume":"43","author":"Lorenzo-Mart\u00edn","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omton.2026.201168_bib29","article-title":"Harnessing TME depicted by histological images to improve cancer prognosis through a deep learning system","volume":"5","author":"Gao","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omton.2026.201168_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep44351","article-title":"Angiopoietin-like 4 Mediates Colonic Inflammation by Regulating Chemokine Transcript Stability via Tristetraprolin","volume":"7","author":"Phua","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201168_bib31","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1038\/s41467-023-42455-4","article-title":"Interferon-gamma couples CD8(+) T cell avidity and differentiation during infection","volume":"14","author":"Uhl","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:36:47Z","timestamp":1790253407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2950329926000445"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201168","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiopoietin-like protein 4 deficiency promotes tumor immune infiltration and CD8+ T cell cytotoxic activity to inhibit tumor progression","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201168"}}